Medicare

Exagen Inc. Reports Strong Fourth Quarter and Full-Year 2023 Results

CARLSBAD, Calif., March 18, 2024 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today reported…

8 months ago

ProSomnus Reschedules Fourth Quarter and Fiscal Year 2023 Investor and Business Update Call

PLEASANTON, Calif., March 15, 2024 (GLOBE NEWSWIRE) -- ProSomnus, Inc. (NASDAQ: OSA) (the “Company”), the leading non-CPAP Obstructive Sleep Apnea (OSA) therapy™,…

8 months ago

Edifecs to Speak at RISE National 2024

Edifecs to lead a panel on AI-driven approaches to improve alternative payment modelsNASHVILLE, Tenn.--(BUSINESS WIRE)--Edifecs, Inc., a global health information…

8 months ago

Neurolutions, Inc. Announces Groundbreaking CMS Decision for IpsiHand™: A Leap Forward in Stroke Rehabilitation

VAN NUYS, Calif.--(BUSINESS WIRE)--The Centers for Medicare & Medicaid Services (CMS) has established a new Healthcare Common Procedure Coding System…

9 months ago

BlueSleep Announces Care Partnership With Shapely

New Collaboration Expands Access to High-Quality Sleep Medicine and Weight-loss PlatformsNEW YORK, NY / ACCESSWIRE / March 12, 2024 /…

9 months ago

Helius Medical Technologies, Inc. Initiates Open-Label Study for Registrational Program in Stroke

-- Enrollment of at least ten patients at Brooks Rehabilitation will begin this month ---- Study will evaluate the use…

9 months ago

CorMedix Inc. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

Conference Call Scheduled for Today at 8:30 a.m. Eastern TimeBERKELEY HEIGHTS, N.J., March 12, 2024 (GLOBE NEWSWIRE) -- CorMedix Inc.…

9 months ago

Bioventus Announces Fourth Quarter and Full Year 2023 Financial Results

Accelerated fourth quarter sales growth to 7.6%, organic growth* of 14.3%Appointed Rob Claypoole as President and Chief Executive Officer, bringing…

9 months ago

BioCardia Announces CMS Approval of Coverage for CardiAMP Cell Therapy Confirmatory Phase III Heart Failure Study

SUNNYVALE, Calif., March 12, 2024 (GLOBE NEWSWIRE) -- BioCardia, Inc. [Nasdaq: BCDA], a developer of cellular and cell-derived therapeutics for…

9 months ago

Neuronetics Announces 5-Year Exclusive Partnership with Transformations Care Network

MALVERN, Pa., March 07, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing,…

9 months ago